About the Emergency response to artemisinin resistance in the Greater Mekong subregion
The emergence of Plasmodium falciparum resistance to artemisinin derivatives in South-East Asia represents a significant challenge for malaria prevention, control and elimination efforts in the region and is a threat to recent gains in malaria control.
In April 2013, WHO launched the Emergency response to artemisinin resistance in the Greater Mekong subregion, Regional framework for action 2013-15. The framework urges malaria partners to work in a coordinated manner to provide malaria interventions to all at-risk risk groups; to achieve tighter coordination and management of field operations; to obtain better information for artemisinin resistance containment; and to strengthen regional oversight and support.
WHO has received support from AusAID and the Bill & Melinda Gates Foundation to strengthen the coordination and technical support to containment activities in the Greater Mekong subregion. The project is being implemented by the WHO Global Malaria Programme, the WHO Regional office for South-East Asia, the WHO Regional office for the Western Pacific and WHO country offices.
A regional hub has been established in Phnom Penh, Cambodia to support and help coordinate activities. Efforts to contain and eventually eliminate parasite resistance are currently ongoing in Cambodia, the Lao People‘s Democratic Republic, Myanmar, Thailand and Viet Nam.
Last update: 6 March 2014